Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

SOME ACTIONS OF PENTAZOCINE ON BEHAVIOR AND BRAIN MONOAMINES IN THE RAT

STEPHEN G. HOLTZMAN and ROBERT E. JEWETT
Journal of Pharmacology and Experimental Therapeutics May 1972, 181 (2) 346-356;
STEPHEN G. HOLTZMAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERT E. JEWETT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The effects of pentazocine, a weak narcotic-antagonist analgesic, were studied on operant behavior (continuous avoidance schedule), locomotor activity and brain nonoamines in the rat. Operant behavior was increased in a graded manner by 2 to 16 mg/kg of pentazocine and decreased by 32 mg/kg. Both stimulant and depressant effects were antagonized by the potent narcotic antagonist naloxone (8 mg/kg) . Pentazocine, 8 to 64 mg/kg, produced a graded increase in locomotor activity which was not prevented by as much as 16 mg/kg of naloxone. Stimulation of locomotor activity was blocked by α-methyltyrosine, an inhibitor of catecholamine synthesis. The total brain content of norepinephrine, dopamine, and serotonin was reduced by pentazocine; turnover rates were not affected. The depletion of the catecholamines was 2½-3½ times greater than that of serotonin. Morphine, in doses as high as 256 mg/kg, caused a much smaller reduction in brain norepinephrine than did pentazocine and elevated brain levels of dopamine. Naloxone (16 mg/kg) failed to block the effects of pentazocine on brain monoamines but did block those of morphine. These findings have been interpreted as follows: 1) the actions of pentazocine on operant behavior appear to be independent of its effects on brain monoamines; 2) stimulation of locomotor activity by pentazocine may be related to the release of brain monoamines; and 3) some of pentazocine's agonistic effects are mediated by mechanisms distinct from those which mediate the actions of morphine.

Footnotes

    • Received July 16, 1971.
    • Accepted February 4, 1972.
  • © 1972 by The Williams & Wilkins Co.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 181, Issue 2
1 May 1972
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
SOME ACTIONS OF PENTAZOCINE ON BEHAVIOR AND BRAIN MONOAMINES IN THE RAT
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

SOME ACTIONS OF PENTAZOCINE ON BEHAVIOR AND BRAIN MONOAMINES IN THE RAT

STEPHEN G. HOLTZMAN and ROBERT E. JEWETT
Journal of Pharmacology and Experimental Therapeutics May 1, 1972, 181 (2) 346-356;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

SOME ACTIONS OF PENTAZOCINE ON BEHAVIOR AND BRAIN MONOAMINES IN THE RAT

STEPHEN G. HOLTZMAN and ROBERT E. JEWETT
Journal of Pharmacology and Experimental Therapeutics May 1, 1972, 181 (2) 346-356;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Toxicity, Biological Activity, and Pharmacokinetics of TXU (Anti-CD7)-Pokeweed Antiviral Protein in Chimpanzees and Adult Patients Infected with Human Immunodeficiency Virus
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics